{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:00:43Z","timestamp":1790910043370,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jmmc-online.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.yjmcc.2017.01.001","type":"journal-article","created":{"date-parts":[[2017,1,6]],"date-time":"2017-01-06T18:18:07Z","timestamp":1483726687000},"page":"40-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Ablation of the cardiac ryanodine receptor phospho-site Ser2808 does not alter the adrenergic response or the progression to heart failure in mice. Elimination of the genetic background as critical variable"],"prefix":"10.1016","volume":"103","author":[{"given":"Francisco J.","family":"Alvarado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9ctor H.","family":"Valdivia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2017.01.001_bb0005","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/CIR.0b013e31829e8807","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2017.01.001_bb0010","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1161\/01.RES.0000062469.83985.9B","article-title":"Cellular basis of abnormal calcium transients of failing human ventricular myocytes","volume":"92","author":"Piacentino","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2017.01.001_bb0015","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1046\/j.1540-8167.2002.00088.x","article-title":"Calcium cycling in heart failure: the arrhythmia connection","volume":"13","author":"Pogwizd","year":"2002","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.yjmcc.2017.01.001_bb0020","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1161\/hh1101.091193","article-title":"Arrhythmogenesis and contractile dysfunction in heart failure: roles of sodium-calcium exchange, inward rectifier potassium current, and residual beta-adrenergic responsiveness","volume":"88","author":"Pogwizd","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2017.01.001_bb0025","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1006\/jmcc.2000.1206","article-title":"Abnormalities of calcium cycling in the hypertrophied and failing heart","volume":"32","author":"Houser","year":"2000","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2017.01.001_bb0030","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0008-6363(97)00277-0","article-title":"Alterations of calcium-regulatory proteins in heart failure","volume":"37","author":"Hasenfuss","year":"1998","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2017.01.001_bb0035","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0092-8674(00)80847-8","article-title":"PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts","volume":"101","author":"Marx","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.yjmcc.2017.01.001_bb0040","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1172\/JCI32726","article-title":"Phosphorylation of the ryanodine receptor mediates the cardiac fight or flight response in mice","volume":"120","author":"Shan","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yjmcc.2017.01.001_bb0045","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1073\/pnas.0510113103","article-title":"Ryanodine receptor\/calcium release channel PKA phosphorylation: a critical mediator of heart failure progression","volume":"103","author":"Wehrens","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yjmcc.2017.01.001_bb0050","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3389\/fphar.2014.00101","article-title":"CaMKII regulation of cardiac ryanodine receptors and inositol triphosphate receptors","volume":"5","author":"Camors","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.yjmcc.2017.01.001_bb0055","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1161\/CIRCRESAHA.112.265579","article-title":"Ryanodine receptor S2808 phosphorylation in heart failure: smoking gun or red herring","volume":"110","author":"Bers","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2017.01.001_bb0060","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1161\/CIRCRESAHA.107.153007","article-title":"Intact beta-adrenergic response and unmodified progression toward heart failure in mice with genetic ablation of a major protein kinase A phosphorylation site in the cardiac ryanodine receptor","volume":"101","author":"Benkusky","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2017.01.001_bb0065","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1161\/CIRCRESAHA.108.174722","article-title":"Adrenergic regulation of cardiac contractility does not involve phosphorylation of the cardiac ryanodine receptor at serine 2808","volume":"102","author":"MacDonnell","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2017.01.001_bb0070","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1161\/CIRCRESAHA.111.255158","article-title":"Hyperphosphorylation of the cardiac ryanodine receptor at serine 2808 is not involved in cardiac dysfunction after myocardial infarction","volume":"110","author":"Zhang","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2017.01.001_bb0075","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1054\/npep.2002.0905","article-title":"Speed congenics: applications for transgenic and knock-out mouse strains","volume":"36","author":"Wong","year":"2002","journal-title":"Neuropeptides"},{"key":"10.1016\/j.yjmcc.2017.01.001_bb0080","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1113\/jphysiol.2013.264689","article-title":"Genetic ablation of ryanodine receptor 2 phosphorylation at Ser-2808 aggravates Ca(2+)-dependent cardiomyopathy by exacerbating diastolic Ca2+ release","volume":"592","author":"Liu","year":"2014","journal-title":"J. Physiol."},{"key":"10.1016\/j.yjmcc.2017.01.001_bb0085","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.yjmcc.2012.03.015","article-title":"PKA phosphorylation of cardiac ryanodine receptor modulates SR luminal Ca2+ sensitivity","volume":"53","author":"Ullrich","year":"2012","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2017.01.001_bb0090","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1172\/JCI37649","article-title":"Role of chronic ryanodine receptor phosphorylation in heart failure and beta-adrenergic receptor blockade in mice","volume":"120","author":"Shan","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yjmcc.2017.01.001_bb0095","doi-asserted-by":"crossref","first-page":"7906","DOI":"10.1073\/pnas.0602133103","article-title":"Stabilization of cardiac ryanodine receptor prevents intracellular calcium leak and arrhythmias","volume":"103","author":"Lehnart","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yjmcc.2017.01.001_bb0100","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nm.1916","article-title":"Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle","volume":"15","author":"Bellinger","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.yjmcc.2017.01.001_bb0105","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1161\/CIRCRESAHA.114.300569","article-title":"Role of RyR2 phosphorylation in heart failure and arrhythmias: protein kinase A-mediated hyperphosphorylation of the ryanodine receptor at serine 2808 does not Alter cardiac contractility or cause heart failure and arrhythmias","volume":"114","author":"Houser","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2017.01.001_bb0110","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1161\/CIRCRESAHA.112.270876","article-title":"Ryanodine receptor phosphorylation and heart failure: phasing out S2808 and \"criminalizing\" S2814","volume":"110","author":"Valdivia","year":"2012","journal-title":"Circ. Res."},{"issue":"Suppl. 16","key":"10.1016\/j.yjmcc.2017.01.001_bb0115","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1681\/ASN.V11suppl_2s101","article-title":"Effect of the genetic background on the phenotype of mouse mutations","volume":"11","author":"Montagutelli","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yjmcc.2017.01.001_bb0120","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/978-1-59745-471-1_23","article-title":"Influence of genetic background on genetically engineered mouse phenotypes","volume":"530","author":"Doetschman","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.yjmcc.2017.01.001_bb0125","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.nbd.2014.09.017","article-title":"Genetic background modulates impaired excitability of inhibitory neurons in a mouse model of Dravet syndrome","volume":"73","author":"Rubinstein","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.yjmcc.2017.01.001_bb0130","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1073\/pnas.93.7.3155","article-title":"Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions","volume":"93","author":"Tu","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yjmcc.2017.01.001_bb0135","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1161\/CIRCRESAHA.114.300568","article-title":"Role of RyR2 phosphorylation in heart failure and arrhythmias: controversies around ryanodine receptor phosphorylation in cardiac disease","volume":"114","author":"Dobrev","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2017.01.001_bb0140","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/CIRCULATIONAHA.111.075382","article-title":"Paradoxical effect of increased diastolic Ca(2+) release and decreased sinoatrial node activity in a mouse model of catecholaminergic polymorphic ventricular tachycardia","volume":"126","author":"Neco","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2017.01.001_bb0145","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1161\/01.RES.0000163276.26083.e8","article-title":"Characterization of a novel PKA phosphorylation site, serine-2030, reveals no PKA hyperphosphorylation of the cardiac ryanodine receptor in canine heart failure","volume":"96","author":"Xiao","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2017.01.001_bb0150","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/CIRCRESAHA.112.274803","article-title":"Heterogeneity of ryanodine receptor dysfunction in a mouse model of catecholaminergic polymorphic ventricular tachycardia","volume":"112","author":"Loaiza","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2017.01.001_bb0155","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bbrc.2008.08.084","article-title":"Ryanodine receptor phosphorylation at Serine 2030, 2808 and 2814 in rat cardiomyocytes","volume":"376","author":"Huke","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yjmcc.2017.01.001_bb0160","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/cvr\/cvm006","article-title":"Sarcoplasmic reticulum Ca2+ leak in heart failure: mere observation or functional relevance?","volume":"77","author":"George","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2017.01.001_bb0165","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.str.2012.04.015","article-title":"Disease mutations in the ryanodine receptor central region: crystal structures of a phosphorylation hot spot domain","volume":"20","author":"Yuchi","year":"2012","journal-title":"Structure"}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282817300019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282817300019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T22:14:31Z","timestamp":1658355271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282817300019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":33,"alternative-id":["S0022282817300019"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2017.01.001","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ablation of the cardiac ryanodine receptor phospho-site Ser2808 does not alter the adrenergic response or the progression to heart failure in mice. Elimination of the genetic background as critical variable","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2017.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}